Etamsylate

This chemical does not meet GHS hazard criteria for 12.2% (5 of 41) of reports.

Warning

H319 (85.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 3 notifications to the ECHA C&L Inventory.；Reported as not meeting GHS hazard criteria per 5 of 41 reports by companies.；There are 2 notifications provided by 36 of 41 reports by companies with hazard statement code(s).；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

B02BX01

B - Blood and blood forming organs；B02 - Antihemorrhagics；B02B - Vitamin k and other hemostatics；B02BX - Other systemic hemostatics；B02BX01 - Etamsylate

QB - Blood and blood forming organs；QB02 - Antihemorrhagics；QB02B - Vitamin k and other hemostatics；QB02BX - Other systemic hemostatics；QB02BX01 - Etamsylate

Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.